David Emerson Jorden bought $9,539 of AURX
CEO/CFO at Nuo Therapeutics, Inc.. 8,773 shares at an average of $1.09, traded Aug 27, 2026, filed Aug 31, 2026.
Score components
- +25RoleCEO
- 0Trade size$10k at market
- -5Relative to holdingsUnder 1% of holdings (0.4%)
- +8Price context67% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-26-029257, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | POpen-market purchase Common Stock | +789 | $1.07 | $844 | 2,062,016 | Aug 31, 2026 |
| Aug 28, 2026 | POpen-market purchase Common Stock | +7,984 | $1.09 | $8,695 | 2,070,000 | Aug 31, 2026 |
Related signals
Other insiders at Nuo Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | AURXsell Nuo Therapeutics, Inc. | David Emerson Jorden CEO/CFO | $300k 200,000 shares | -9% | |
| 19Weak | AURXbuy Nuo Therapeutics, Inc. | Charles E Sheedy owner | $200k 133,333 shares | +1% | |
| 25Weak | AURXbuy Nuo Therapeutics, Inc. | Charles E Sheedy owner | $94k 125,000 shares | +1% | |
| 18Weak | AURXbuy Nuo Therapeutics, Inc. | Charles E Sheedy owner | $75k 100,000 shares | +1% | |
| 23Weak | AURXbuy Nuo Therapeutics, Inc. | Charles E Sheedy owner | $75k 150,000 shares | +1% | |
| 38Weak | AURXsell Nuo Therapeutics, Inc. | David Emerson Jorden CEO/CFO | $244k 162,500 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.